Awruch J, Tomaro M L, Frydman R B, Frydman B
Biochim Biophys Acta. 1984 Jun 14;787(2):146-51. doi: 10.1016/0167-4838(84)90073-6.
The substrate specificity of the different molecular forms of biliverdin reductase (bilirubin:NAD(P)+ oxidoreductase, EC 1.3.1.24) using biliverdin XIII alpha, XIII beta and XIII gamma was examined. It was found that molecular form 1 (the major form in normal rat liver) reduced biliverdin XIII alpha at a much higher rate than the other two isomers. Molecular form 2 (the minor form) reduced isomers XIII alpha and XIII beta at similar rates, while molecular form 3 (the major form induced by CoCl2 treatment) reduced the XIII beta isomer at a slightly higher rate than the XIII alpha isomer. Molecular forms 2 and 3, both reduced isomer XIII gamma more slowly than they reduced the XIII alpha and XIII beta isomers. These results are similar to those obtained previously using biliverdins IX alpha, IX beta and IX gamma, suggesting that biliverdin reductase specificity is related to the type of the isomer rather than to the series (IX or XIII) of the isomer.
研究了使用胆绿素 XIIIα、XIIIβ 和 XIIIγ 时,胆绿素还原酶(胆红素:NAD(P)+氧化还原酶,EC 1.3.1.24)不同分子形式的底物特异性。结果发现,分子形式 1(正常大鼠肝脏中的主要形式)还原胆绿素 XIIIα 的速率比其他两种异构体高得多。分子形式 2(次要形式)以相似的速率还原异构体 XIIIα 和 XIIIβ,而分子形式 3(由 CoCl2 处理诱导的主要形式)还原 XIIIβ 异构体的速率略高于 XIIIα 异构体。分子形式 2 和 3 还原异构体 XIIIγ 的速度都比它们还原 XIIIα 和 XIIIβ 异构体的速度慢。这些结果与先前使用胆绿素 IXα、IXβ 和 IXγ 获得的结果相似,表明胆绿素还原酶的特异性与异构体的类型有关,而不是与异构体的系列(IX 或 XIII)有关。